Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 2 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 30 % of short-term debt in 2025; threshold 65 %.
-
Figures corrected NBB
Corrected annual account filed for 2022.
Financials
Financial year 2025
LABORATOIRE DE L'INSTITUT MEDICAL SPECIALISE from Ottignies-Louvain-la-Neuve, company number BE0424567020, closed financial year 2025 with a result of € -6.2 million after tax. For that financial year LABORATOIRE DE L'INSTITUT MEDICAL SPECIALISE recorded revenue of € 37.9 million and equity of € -5.8 million. Compared with financial year 2024, the result moved from € -1.6 million to € -6.2 million. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 28, 2026.
€ -5.8 million
▼ € 6.2 million vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -6.2 million
▼ 291 % more loss than in 2024
Profit after tax over the fiscal year.
€ 942,838
▲ 15% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -8.9 million.
People and assets in 2025
191.8
▲ 36.9 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 9.1 million
▲ 7% vs 2024
€ 47,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 2.4 million
▼ 12% vs 2024
Of which on lease € 1.8 million.
Debts at end 2025
€ 6.3 million
▼ 23% vs 2024
€ 1.1 million is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 11.6 million
▲ 5% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 138 days on average.
€ 6.4 million
▲ 17% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 34,653,664 | € 33,796,471 | € 33,784,849 | € 37,890,058 | ▲ 12% |
| Profit after taxes | € 963,506 | € -10,512,778 | € -1,582,228 | € -6,193,378 | ▼ € 4.6 million |
| Equity | € 3,903,714 | € -6,609,064 | € 408,708 | € -5,784,670 | ▼ € 6.2 million |
| Total debts | € 17,912,351 | € 27,801,176 | € 26,139,913 | € 27,914,655 | ▲ 7% |
| Cash | € 823,629 | € 494,140 | € 816,953 | € 942,838 | ▲ 15% |
| Retained profit | € 753,714 | € -9,759,064 | € -2,741,292 | € -8,934,670 | ▼ € 6.2 million |
| Bank debt | € 6,049,025 | € 13,404,833 | € 8,170,528 | € 6,326,928 | ▼ 23% |
| Balance sheet total | € 21,925,871 | € 21,509,839 | € 26,668,711 | € 22,327,985 | ▼ 16% |
| Employees (FTE) | 161.6 | 151.1 | 154.9 | 191.8 | ▲ 36.9 |
Key figures of LABORATOIRE DE L'INSTITUT MEDICAL SPECIALISE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to LABORATOIRE DE L'INSTITUT MEDICAL SPECIALISE?
What happened at LABORATOIRE DE L'INSTITUT MEDICAL SPECIALISE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 6.2 million. Source: NBB ↗
- Philippe CHARRIER stepped down as director. NBB
- Philippe CHARRIER became a director. NBB
- New establishment in Ottignies-Louvain-la-Neuve. KBO
- New establishment in Boussu. KBO
- Start of the company according to the CBE. KBO
In short
From € 963,506 profit in 2022 to € 6.2 million loss in 2025.
Paid € 391,378 in corporate taxes since 2022.
Best year ever: 2022, with € 963,506 profit.
Pays suppliers within 138 days on average.
A new publication or filing at LABORATOIRE DE L'INSTITUT MEDICAL SPECIALISE? We notify you, reason included.
Follow LABORATOIRE DE L'INSTITUT MEDICAL SPECIALISEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of ACTIS BELGIUM comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
LABORATOIRE DE L'INSTITUT MEDICAL SPECIALISEThe shares are held by MB NEXT GROUP EUROPE (66.7%) and ACTIS BELGIUM (37.7%).
Directors
According to the 2025 annual accounts
since 2024 · until 2026
Shareholders
MB NEXT GROUP EUROPE
66.7%
37.7%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Fond des Més 5 box tour F
1348 Ottignies-Louvain-la-Neuve
Rue de Mons(H) 230
7301 Boussu
Active since 1 September 1983
Fond des Més 5
1348 Ottignies-Louvain-la-Neuve
Active since 21 April 2016
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 8 companies are registered at this address.
All companies at this address →O'Shenu Technologies
€ -78,497 gross margin · 2025
KESTAR
€ -5,434 gross margin · 2024
Mountvector Bio
€ -24,837 gross margin · 2025
ATMP BIO
€ -1,416 gross margin · 2025
East Lake High-Tech Europe
+3 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Certifications & Partners
Hosting & Email
Email provider
Microsoft 365
Hosting
AUTOMATTIC - Automattic, Inc, US
DNS
OVH DNS
Website info
Features
Security
Network
Details
- Company number
- 0424.567.020
- VAT number
- BE 0424.567.020
- Registered office
- Fond des Més 5 bus tour F, 1348 Ottignies-Louvain-la-Neuve
- Names & denominations
- LABORATOIRE DE L'INSTITUT MEDICAL SPECIALISE · L.I.M.S.
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 10 May 1983
- Peppol
- Active · Active since 20 Nov 2020
- Contact
- lims-mbnext.be
- Activities · NACE
Activiteiten van medische beeldvorming en medische laboratoria
Activiteiten van medische laboratoria